These findings underscore the complexity of prognostic stratification in Luminal B breast cancer: while transcriptomic analysis shows the WWOX/HIF1A ratio is strongly associated with pathway changes and biological features linked to risk, in multivariate analyses, only clinical stage retains independent significance. This evidence concerns the gene WWOX and breast carcinoma.